On June 20-22, 2016, Chief Justice Hinkson of the British Columbia Supreme Court, Justice Perell of the Ontario Superior Court and Justice Corriveau of the Cour Superior du Quebec held joint hearings in Toronto, Ontario to consider the applications of the Joint Committee and the federal government about the surplus in the 1986 to 1990 Hepatitis C Settlement Agreement Trust Fund which is estimated to be between $207 million and $256 million as at December 31, 2013.
The decisions of Justice Perell and Justice Corriveau on the applications to allocate excess capital were released on August 15, 2016. The decision of Chief Justice Hinkson on the applications to allocate excess capital was released on August 16, 2016. Each of the courts approved 7 of the 9 recommendations (with some modifications) made by the Joint Committee. Each of the courts dismissed the application of Canada to have the excess capital paid to Canada. Links to the decisions of the courts appear below. The parties have appeal rights according to the rules of court in each jurisdiction. The Joint Committee is considering these decisions and will provide updates on this website on next steps and developments.
Copies of the materials that have been filed with each of the Courts including the written submissions to the Courts from each of the parties can be reviewed by clicking on the links to the applicable province below.
We're here to help you
In this Web site, you will find important
information on key aspects of the Hepatitis C (HCV)
January 1, 1986-July 1, 1990 Class Actions Settlement.
Please note that the settlement is for the benefit of
two main groups:
Persons who were infected with HCV
for the first time through blood transfusions during
the period of January 1, 1986 to July 1, 1990,
and certain members of their families;
Persons with certain congenital
clotting deficiencies (hemophilia) or Thalassemia
Major who contracted HCV and received Blood and
blood products in Canada during the period of January
1, 1986 to July 1, 1990, and certain members
of their families.
Please read the information on this Web site
very carefully. This will help you to determine
whether you are eligible or not for compensation
as a member of one of the two groups identified above. Once you have read and reviewed the information
contained in this Web site, you can contact
the Administrator if you have any questions or comments.
To do so, you may send an email or call us toll-free, at 1-877-434-0944.
Our business hours are 8:30 am to 4:30 pm, Eastern Time, Monday to Friday.
DID YOU KNOW?
- A key feature of the benefits under The 1986-1990 Hepatitis C Settlement Agreement is that Approved HCV Infected Class Members are able to return for additional compensation if their Disease progresses. For example, you may have been entitled to Level 2 compensation in the past, but if your Disease has already progressed or does progress in the future you may be approved at a higher disease level and awarded additional compensation. Please contact the Administrator for further information regarding this important feature of the Settlement Agreement.
- If you are an Approved Class Member you may be eligible for reimbursement for uninsured costs of HCV treatment and medications in addition to out-of-pocket expenses such as travel costs associated with seeking medical advice and treatment regarding your Hepatitis C.
- It is important to designate an Executor of your Estate in your Will for the continuation of your claim in the event that you may pass away. It is also important to inform your Executor to contact the Administrator regarding your claim under the 1986-1990 Hepatitis C Settlement Agreement as compensation may be available to your family members if Hepatitis C has materially contributed to your death. Please note that certain claim deadlines will apply to family member applications.
- You can add your email address to your file by emailing us at email@example.com and we will update or add your email address to your file. Your email address will remain strictly confidential and will not be distributed.
Any person who submits a statement of claim to the Administrator containing intentionally inaccurate and/or false information in order to obtain undue benefits under the Agreement is liable to criminal and/or civil action.
March 4, 2015 – Recent HCV Diagnosis Exception to the June 30, 2010 First Claim Deadline
The Court has amended a protocol with regards to issuing Initial Claim Packages to individuals who first learned of their infection with HCV within three (3) years prior to first having advised the Administrator of a potential claim. To view the Court Approved Protocol, click here
March 4, 2015 - Issuance of Initial Claims Packages after the June 30, 2010 First Claim Deadline
The Court has amended a protocol with regards to issuing Initial Claim Packages to individuals upon request, provided that certain conditions are met. To view the Court Approved Protocol, click here
May 1, 2014 – Request Form – Deficiency Deadline Extension
Should you wish to request and extension of your Deficiency Deadline, please submit a “Request Form – Deficiency Deadline Extension” setting out (a) the steps already taken to cure the deficiencies; (b) the reasons why the deficiencies have not been cured to date; and (c) the new steps you propose to take to cure the deficiencies and how long these steps will take. To view and print a “Request Form – Deficiency Deadline Extension”, click here.
May 1, 2014 – Deficient Claims, Claimants that Cannot be Located and Duplicate Claims
The Court has approved a protocol with regards to Deficient Claims, Claimants that Cannot be Located and Duplicate Claims. To view the Court Approved Protocol, click here.
Pre 1986 / Post 1990 Settlement
For further information on that settlement visit
Payments to approved claimants
Approved and denied claims